What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Akihiro Inoue(Ehime University), Takeharu Kunieda(Ehime University), Seiji Shigekawa(Ehime University), Shingo Kinnami(Ehime University Hospital), Hideaki Watanabe(Showa University Northern Yokohama Hospital), Kazuhisa Kanno(Ehime University Hospital), Takanori Ohnishi(Saiseikai Matsuyama Hospital), Mie Kurata(Ehime University), Mashio Taniwaki(Ehime University Hospital), Kosuke Kusakabe(Ehime University), Daisuke Yamashita(University of Alabama at Birmingham), Shirabe Matsumoto(Ehime University), Satoshi Suehiro(Ehime University), Riko Kitazawa(Ehime University Hospital), Yukihiro Miyazaki(Ehime University Hospital), Takatsugu Honda(Ehime University Hospital)
Cited by 9
Related Papers
Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
|Stem Cells International|2018|68
Targeting glioma-initiating cells via the tyrosine metabolic pathway
|Journal of neurosurgery|2020|42
CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
|Cancer Medicine|2021|26